Use of untested 'Wolverine' peptide backed by RFK Jr. on the rise, study finds

A recent study indicates a rise in the use of the untested BPC-157 peptide, which has received backing from RFK Jr. Individuals primarily initiate the use of this 'Wolverine' peptide to manage gastrointestinal symptoms or pain. The data shows that BPC-157 is most frequently obtained through gray-market peptide vendors or compounding pharmacies. The findings highlight the growing trend of utilizing these specific substances for therapeutic purposes despite their untested status in medical settings.